The global continuous renal replacement therapy market was valued at USD 1,356.7 million in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 8.6% from 2023 to 2030. Factors contributing to this growth include the rising incidence of acute kidney injury (AKI), an increase in sepsis cases, the rapid expansion of hospitals and urgent care centers, growing hospital admission...